17 Lee Blvd, Malvern, PA 19355
customerservice@reniguard.com
Home
August
2011, Reniguard received a Phase I SBIR grant from NIH to develop tests
for early detection of HBV drug resistance.
5/19/2010, World Hepatitis Day.
Reniguard joined a historical rally, organized by the
National Viral Hepatitis Roundtable,
at Washington DC, to
urge the Congress to
increase federal funding for chronic viral hepatitis screening,
education, and early intervention programs.
May
2010, Reniguard received funding from the
Ben Franklin Technology
Partners to develop an assay kit for ultrasensitive quantification of
the KRas codon 12/13 mutants
for clinical diagnosis and prognosis purposes.
June
2009, Reniguard received the Technology Commercialization Network (TCN)
engagement funding from the Ben Franklin Technology Partners for the
development of ultrasensitive mutant quantification technologies to
detect the KRas codon 12/13 mutations.
News & Events
Copy
right
©2011
Reniguard Life Sciences Inc.
All right reserved.